| Date Filed | Type | Description |
| 06/02/2023 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 shares
@ $0
Paid exercise price by delivering 4,150 shares
@ $26.07, valued at
$108.2k
|
|
| 06/02/2023 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Gifted 10,000 shares
@ $0
Granted 30,000 shares
@ $0
Paid exercise price by delivering 12,165 shares
@ $26.07, valued at
$317.1k
|
|
| 06/02/2023 |
4
| Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 shares
@ $0
Paid exercise price by delivering 4,150 shares
@ $26.07, valued at
$108.2k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/18/2023 |
4
| Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/18/2023 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/18/2023 |
4
| Noonberg Sarah B. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/18/2023 |
4
| O'Dowd Sarah A (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/18/2023 |
4
| SELICK HAROLD E (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 01/18/2023 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 20,625 shares
@ $0
Granted 123,750 options to buy
@ $12.17, valued at
$1.5M
|
|
| 01/18/2023 |
4
| Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 10,625 shares
@ $0
Granted 63,750 options to buy
@ $12.17, valued at
$775.8k
|
|
| 01/18/2023 |
4
| MOLINA ARTURO MD (Chief Medical Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 3,125 shares
@ $0
Granted 18,750 options to buy
@ $12.17, valued at
$228.2k
|
|
| 01/18/2023 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Gifted 3,000 shares
@ $0
Gifted 3,116 shares
@ $0
Granted 600,000 options to buy
@ $12.17, valued at
$7.3M
|
|
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/24/2022 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 20,000 options to buy
@ $4.21, valued at
$84.2k
|
|
| 05/27/2022 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $8.31, valued at
$166.2k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Noonberg Sarah B. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $8.31, valued at
$166.2k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 20,000 options to buy
@ $8.31, valued at
$166.2k
|
|
| 05/04/2022 |
4
| Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 12,000 options to buy
@ $8.59, valued at
$103.1k
|
|
| 05/04/2022 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 15,742 options to buy
@ $4.21, valued at
$66.3k
|
|
| 04/26/2022 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 40,000 options to buy
@ $7.38, valued at
$295.2k
|
|
| 04/26/2022 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 30,000 options to buy
@ $4.21, valued at
$126.3k
|
|
| 04/19/2022 |
4
| Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 13,750 shares
@ $0
Granted 82,500 options to buy
@ $19.19, valued at
$1.6M
|
|
| 04/19/2022 |
3
| Ali Asif (CFO) has filed a Form 3 on Protagonist Therapeutics, Inc |
| 04/14/2022 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 34,087 options to buy
@ $1.89, valued at
$64.4k
|
|
| 03/02/2022 |
4
| Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 649 shares
@ $24.28, valued at
$15.8k
|
|
| 03/02/2022 |
4
| PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 4,648 shares
@ $24.28, valued at
$112.9k
|
|
| 03/02/2022 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Paid exercise price by delivering 2,119 shares
@ $24.28, valued at
$51.4k
|
|
|